Keisei Anan

1.1k total citations
49 papers, 802 citations indexed

About

Keisei Anan is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Keisei Anan has authored 49 papers receiving a total of 802 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Cancer Research, 27 papers in Oncology and 14 papers in Pathology and Forensic Medicine. Recurrent topics in Keisei Anan's work include Breast Cancer Treatment Studies (28 papers), Cancer Treatment and Pharmacology (14 papers) and Breast Lesions and Carcinomas (13 papers). Keisei Anan is often cited by papers focused on Breast Cancer Treatment Studies (28 papers), Cancer Treatment and Pharmacology (14 papers) and Breast Lesions and Carcinomas (13 papers). Keisei Anan collaborates with scholars based in Japan, United States and Switzerland. Keisei Anan's co-authors include Takashi Morisaki, Motomichi Torisu, Mitsuo Katano, Akashi Ikubo, Shoshu Mitsuyama, Masao Tanaka, Yutaka Tokuda, Masao Tanaka, Akihiko Uchiyama and Ai Tomotaki and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and British Journal of Cancer.

In The Last Decade

Keisei Anan

46 papers receiving 781 citations

Peers

Keisei Anan
Keisei Anan
Citations per year, relative to Keisei Anan Keisei Anan (= 1×) peers Lola Anagnostaki

Countries citing papers authored by Keisei Anan

Since Specialization
Citations

This map shows the geographic impact of Keisei Anan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keisei Anan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keisei Anan more than expected).

Fields of papers citing papers by Keisei Anan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keisei Anan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keisei Anan. The network helps show where Keisei Anan may publish in the future.

Co-authorship network of co-authors of Keisei Anan

This figure shows the co-authorship network connecting the top 25 collaborators of Keisei Anan. A scholar is included among the top collaborators of Keisei Anan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keisei Anan. Keisei Anan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sasada, Shinsuke, Naoto Kondo, Hiroya Hashimoto, et al.. (2023). Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a/bN0M0 breast cancer. Breast Cancer Research and Treatment. 202(3). 473–483. 2 indexed citations
2.
Miyashita, Minoru, Naoki Niikura, Hiraku Kumamaru, et al.. (2019). Role of Postmastectomy Radiotherapy After Neoadjuvant Chemotherapy in Breast Cancer Patients: A Study from the Japanese Breast Cancer Registry. Annals of Surgical Oncology. 26(8). 2475–2485. 18 indexed citations
3.
Saimura, Michiyo, Kenichiro Koga, Keisei Anan, Shoshu Mitsuyama, & Sadafumi Tamiya. (2018). Diagnosis, characteristics, and treatment of breast carcinomas within benign fibroepithelial tumors. Breast Cancer. 25(4). 470–478. 8 indexed citations
4.
Shien, Tadahiko, Hiroyoshi Doihara, Nobuaki Sato, et al.. (2017). Serum lipid and bone metabolism effects of Toremifene vs. Letrozole as adjuvant therapy for postmenopausal early breast cancer patients: results of a multicenter open randomized study. Cancer Chemotherapy and Pharmacology. 81(2). 269–275. 7 indexed citations
5.
Iwamoto, Takayuki, Hiraku Kumamaru, Hiroaki Miyata, et al.. (2016). Distinct breast cancer characteristics between screen- and self-detected breast cancers recorded in the Japanese Breast Cancer Registry. Breast Cancer Research and Treatment. 156(3). 485–494. 19 indexed citations
6.
Iwamoto, Takayuki, Takayuki Kinoshita, Keisei Anan, et al.. (2015). Comprehensive prognostic report of the Japanese Breast Cancer Society registry in 2006. Breast Cancer. 23(1). 62–72. 8 indexed citations
8.
Nishimura, Reiki, Nobuyuki Arima, Satoshi Toyoshima, et al.. (2012). Evaluation of PTEN loss and PIK3CA mutations and their correlation with efficacy of trastuzumab treatment in HER2-positive metastatic breast cancer: A retrospective study (KBC-SG 1001). Molecular and Clinical Oncology. 1(1). 47–52. 6 indexed citations
9.
Masuda, Norikazu, Yoshiaki Rai, Keisei Anan, et al.. (2011). Monthly versus 3-monthly goserelin acetate treatment in pre-menopausal patients with estrogen receptor-positive early breast cancer. Breast Cancer Research and Treatment. 126(2). 443–451. 30 indexed citations
10.
Anan, Keisei, Shoshu Mitsuyama, Yasuhiro Yanagita, et al.. (2011). Effects of toremifene and anastrozole on serum lipids and bone metabolism in postmenopausal females with estrogen receptor–positive breast cancer: the results of a 2-year multicenter open randomized study. Breast Cancer Research and Treatment. 128(3). 775–781. 7 indexed citations
12.
Ōno, Minoru, et al.. (2006). Isoechoic axillary lymph node metastases of mucinous carcinoma of the Breast: A case report. Breast Cancer. 13(4). 382–385. 6 indexed citations
13.
Anan, Keisei, Shoshu Mitsuyama, Kazuyoshi Nishihara, et al.. (2004). Breast cancer in Japanese men: Does sex affect prognosis?. Breast Cancer. 11(2). 180–186. 11 indexed citations
14.
Anan, Keisei, Shoshu Mitsuyama, Kazuyoshi Nishihara, et al.. (2003). Increased dihydropyrimidine dehydrogenase activity in breast cancer. Journal of Surgical Oncology. 82(3). 174–179. 11 indexed citations
15.
Anan, Keisei, Shoshu Mitsuyama, Kazuyoshi Nishihara, et al.. (2002). Postoperative Follow-Up of Patients with Early Breast Cancer: Reappraisal of Serum Tumor Markers. Surgery Today. 32(1). 13–18. 5 indexed citations
16.
Anan, Keisei, Shoshu Mitsuyama, Kazuyoshi Nishihara, et al.. (2000). Tubular Carcinoma of the Breast: A Histologic Subtype Indicative of Breast-Conserving Therapy. Surgery Today. 30(12). 1057–1061. 9 indexed citations
17.
Anan, Keisei, Takashi Morisaki, Mitsuo Katano, et al.. (1997). Preoperative assessment of tumor angiogenesis by vascular endothelial growth factor mRNA expression in homogenate samples of breast carcinoma: Fine-needle aspirates vs. resection samples. Journal of Surgical Oncology. 66(4). 257–263. 5 indexed citations
18.
Morisaki, Takashi, Mitsuo Katano, Akashi Ikubo, et al.. (1996). Immunosuppressive cytokines (IL-10, TGF-β) genes expression in human gastric carcinoma tissues. Journal of Surgical Oncology. 63(4). 234–239. 36 indexed citations
19.
Tsukahara, Yasuhiro, et al.. (1996). Role of Nitric Oxide Derived from Alveolar Macrophages in the Early Phase of Acute Pancreatitis. Journal of Surgical Research. 66(1). 43–50. 53 indexed citations
20.
Ikubo, Akashi, Takashi Morisaki, Mitsuo Katano, et al.. (1995). A possible role of TGF-β in the formation of malignant effusions. Clinical Immunology and Immunopathology. 77(1). 27–32. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026